Question: Anticoagulants Are The Mainstay Of Prevention And Treatment Of Venous Thromboembolism Because Fibrin Is The Predominant Component Of Venous Thrombi. Fibrinolytic Therapy Is Used In Selected Patients With Venous Thromboembolism. Anticoagulants Are The Mainstay Of Prevention And Treatment Of Venous Thromboembolism Because Fibrin Is The Predominant Component …

Anticoagulants are the mainstay of prevention and treatment of venous thromboembolism because fibrin is the predominant component of venous thrombi. Fibrinolytic therapy is used in selected patients with venous thromboembolism. Anticoagulants are the mainstay of prevention and treatment of venous thromboembolism because fibrin is the predominant component of venous thrombi. Antiplatelet drugs are less effective than anticoagulants in this setting because of the limited platelet content of venous thrombi. Fibrinolytic therapy us used in selected patients with venous thromboembolism. For example, patients with massive or submissive PE can benefit form systemic or catheter-directed fibrinolyctic therapy. Reply … Tyree Hunter Mar 27, 2021 at 1:30 PM Thank you for your post Ruth. Your are correct in how anticoagulant and Horinolytics are used to treat patients. Are they the same or different, why or why not? Pr…us Dashboard Calendar To Do Notifications Inbox